Seeking Alpha

Credit Suisse is recommends taking advantage of recent weakness to buy Health Management (HMA...

Credit Suisse is recommends taking advantage of recent weakness to buy Health Management (HMA +0.7%). The firm says it's not concerned with recent headlines and believes organic growth estimates will prove conservative. The firm rates the shares at Outperform with a $12 price target.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs